Damora Therapeutics Inc Sustainability Reports
Damora Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapies for hematological disorders, with a specific focus on mutant calreticulin-driven myeloproliferative neoplasms.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00XMLGWD4
2 reports from 2021 to 2024
Company Profile
Damora Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapies for hematological disorders, with a specific focus on mutant calreticulin-driven myeloproliferative neoplasms.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
